Ngā hua rapu - Roberto Zarrabeitia

  • E whakaatu ana i te 1 - 7 hua o te 7
Whakamahine hua
  1. 1
    Estrogen therapy for hereditary haemorrhagic telangiectasia (HHT): Effects of raloxifene, on Endoglin and ALK1 expression in endothelial cells

    Estrogen therapy for hereditary haemorrhagic telangiectasia (HHT): Effects of raloxifene, on Endoglin and ALK1 expression in endothelial cells mā Virginia Albiñana, Maria Bernabeu-Herrero, Roberto Zarrabeitia, Carmelo Bernabéu, Luisa M. Botella

    I whakaputaina 2010
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    Propranolol as antiangiogenic candidate for the therapy of hereditary haemorrhagic telangiectasia

    Propranolol as antiangiogenic candidate for the therapy of hereditary haemorrhagic telangiectasia mā Virginia Albiñana, Lucía Recio-Poveda, Roberto Zarrabeitia, Carmelo Bernabéu, Luisa M. Botella

    I whakaputaina 2012
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    Quality of life in patients with hereditary haemorrhagic telangiectasia (HHT)

    Quality of life in patients with hereditary haemorrhagic telangiectasia (HHT) mā Roberto Zarrabeitia, Concepción Fariñas-Álvarez, Miguel Santibáñez, Blanca Señaris, Ana Fontalba, Luisa M. Botella, José Antonio Parra

    I whakaputaina 2017
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    Ocular lesions in hereditary hemorrhagic telangiectasia: genetics and clinical characteristics

    Ocular lesions in hereditary hemorrhagic telangiectasia: genetics and clinical characteristics mā Gómez-Acebo, Inés, Prado, Sara Rodríguez, De La Mora, Ángel, Puente, Roberto Zarrabeitia, de la Roza Varela, Beatriz, Dierssen-Sotos, Trinidad, Llorca, Javier

    I whakaputaina 2020
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:
  5. 5
    Therapeutic action of tranexamic acid in hereditary haemorrhagic telangiectasia (HHT): Regulation of ALK-1/endoglin pathway in endothelial cells

    Therapeutic action of tranexamic acid in hereditary haemorrhagic telangiectasia (HHT): Regulation of ALK-1/endoglin pathway in endothelial cells mā Africa Fernández-L, Eva M. Garrido-Martín, Francisco Sanz-Rodrı́guez, Jose-Ramon Ramirez, Carmelo Morales‐Angulo, Roberto Zarrabeitia, Alfonso Perez-Molino, Carmelo Bernabéu, Luisa M. Botella

    I whakaputaina 2007
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  6. 6
    Safety of thalidomide and bevacizumab in patients with hereditary hemorrhagic telangiectasia

    Safety of thalidomide and bevacizumab in patients with hereditary hemorrhagic telangiectasia mā Elisabetta Buscarini, Luisa M. Botella, Urban W. Geisthoff, Anette Drøhse Kjeldsen, Hans Jurgen Mager, Fabio Pagella, Patrizia Suppressa, Roberto Zarrabeitia, Sophie Dupuis‐Girod, Claire L. Shovlin

    I whakaputaina 2019
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  7. 7
    Graded contrast echocardiography in pulmonary arteriovenous malformations

    Graded contrast echocardiography in pulmonary arteriovenous malformations mā José Hernán Parra Sánchez, J. Bueno, Jesús Zarauza, Concepción Fariñas-Álvarez, Jose María Luzón Cuesta, Pastor Luna Ortíz, Roberto Zarrabeitia, A. Molino, Manuel Bustamante Montalvo, Luisa M. Botella, Marco Delgado

    I whakaputaina 2009
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: